30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union
5 March 2018 EMA/825017/2015 Rev.1 Human Medicines Evaluation
The timetables in this document may be subject to revision
Marketing authorisation renewal application - ATMP Assessment of initial submission (90-day timetable) Assessment of responses to Request for Supplementary Information (30-day timetable after clock-stop for responses) Assessment of responses to Request for Supplementary Information (30-day timetable after immediate responses)
(*) Renewal applications must be submitted at least nine months before the actual expiry date of the marketing authorisation, i.e. the 5-year anniversary of the Commission Decision granting or renewing the marketing authorisation and irrespective of whether the marketing authorisation may be suspended. The start of the evaluation process will be the next possible date in the table after submission and validation of the dossier. The MAHs should agree in advance the submission date of the renewal application with the Agency. The Agency strongly recommends submitting the application before the published submission deadline. This is to avoid missing the target start date as a result of a technically invalid eCTD submission, in which case the submission is considered void and needs to be re-despatched. (^) The validation period between submission date and start date is usually sixteen calendar days. (**) Comments from PRAC, CAT and CHMP members are not made available to Marketing Authorisation Holders (MAHs). (***) An updated AR is optional and dependent on the comments received from committee (PRAC, CAT, CHMP) members which create the need for the update. (#) Step applicable only in case of CAT Opinion (not applicable in case a Request for Supplementary Information is adopted by the CAT).
(*) The Agency strongly recommends submitting the application before the published submission deadline. This is to avoid missing the target start date as a result of a technically invalid eCTD submission, in which case the submission is considered void and needs to be re-despatched. (**) Comments from PRAC, CAT and CHMP members are not made available to Marketing Authorisation Holders (MAHs). (***) An updated AR is optional and dependent on the comments received from committee (PRAC, CAT, CHMP) members which create the need for the update.
(¹) This timetable is only applicable when minor issues remain. (*) The Agency strongly recommends submitting the application before the published submission deadline. This is to avoid missing the target start date as a result of a technically invalid eCTD submission, in which case the submission is considered void and it needs to be re-despatched. (**) Comments from CAT and CHMP members are not made available to Marketing Authorisation Holders (MAHs). (***) An updated AR is optional and dependent on the comments received from committee (CAT and CHMP) members which create the need for the update.
Marketing authorisation renewal application - ATMP - European ...
Reproduction is authorised provided the source is acknowledged. Page 1 / 7. EMA/825017/2015 Rev.1. Human Medicines Evaluation. The timetables in this document may be subject to revision. Marketing authorisation renewal application - ATMP. Assessment of initial submission (90-day timetable). Assessment of ...
The validation period between submission date and start date is usually sixteen calendar days. (**) Comments from PRAC and CHMP members are not made available to Marketing Authorisation Holders. (***) An updated AR is optional and dependent on the co
Jan 1, 2017 - Understand the access to EudraVigilance provided via the EudraVigilance Data Analysis. System (EVDAS). ⢠Be familiar with the EVDAS user ...
Oct 7, 2016 - Applications by marketing authorisation holders (MAHs). Guidance for ... Issues identified during validation will be notified to the MAH via email.
Jan 1, 2017 - Revised definition and process for emerging safety issues, previously addressed in GVP. Module VI. ⢠Streamlined information on scientific aspects of signal management. ⢠Clarifications on terminology, roles and responsibilities and
Jan 1, 2017 - download (*EVPM). ICSR creation. ICSR ... The following illustration shows the report's filters. EV-M5b - EVDAS .... Grouping is a manual activity performed by the Agency to facilitate such analysis. ...... The ICSR is provided in PDF f
Jan 1, 2018 - ... has introduced a number of measures via new or revised texts in the human field to promote 3Rs. These requirements are published in Supplement 9.3 and are in force from 01/01/2018. 1 Correction in title of document. 2 Available at h
What business goal was the project intended to deliver? ... the reliability of the software applications was improved (because our team developed unit tests and.
The EMA emphasises the importance of pre-submission meetings between applicants and the EMA/(Co-. ) Rapporteur. Pre-submission meetings (which should take place approximately 7 months prior to the anticipated date of submission of the application) ar
Oct 10, 2016 - feedback from Marketing Authorisation Holders (MAHs), to increase .... The communication took place via email/Eudralink in 100% of cases, ...
Jan 1, 2018 - highlighting recent measures in the veterinary field to promote reduction ... Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a ... In the EU, after 1 January 2013,
